A single-center prospective observational study evaluates the correlation between an AI-based bowel preparation quality score (FQ-BBPS\[25%\]), which quantifies fecal coverage area during colonoscopy withdrawal, and the adenoma detection rate (ADR) in screening/surveillance patients.
aged 45-75 years
No colonoscopy within the past 3 years
Patients scheduled for therapeutic colonoscopy, postoperative surveillance after colorectal surgery, or treatment of histologically confirmed polyps
Patients with highly suspected or pathologically confirmed colorectal cancer
Patients presenting with alarm symptoms or signs (hematochezia, melena, unexplained anemia or weight loss, palpable abdominal mass, or a positive digital rectal examination)
Pregnant or breastfeeding women
Patients undergoing screening/surveillance colonoscopy
Cohort
Cross-sectional
Not listed
adenoma detection rate
sessile serrated lesion detection rate
advanced adenoma detection rate
polyp detection rate
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
